Coherus BioSciences (CHRS) Narrows Q4 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Coherus BioSciences (CHRS) Files $100M Common SHelf
March 23, 2015 4:32 PM EDTCoherus BioSciences (NASDAQ: CHRS) filed to sell up to $100 million of its common stock.
... More